Novartis India Limited

This company provides pharmaceuticals, generics, OTC and animal healthcare products in various therapeutic areas.

1947 | Mumbai, Maharashtra (India) | Active
Last Updated:

Novartis India Profile

Key Indicators

  • Authorised Capital ₹ 32.00 Cr
  • Paid Up Capital ₹ 12.35 Cr
  • Company Age 77 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 257.48 Cr
  • Revenue Growth 0.88%
  • Profit Growth 2878.49%
  • Ebitda 140.06%
  • Net Worth 12.14%
  • Total Assets 2.65%

About Novartis India

Novartis India Limited (NIL) was founded in India on 13 December 1947 and has a glorious history of 77 years and four months. Its registered office is in Mumbai, Maharashtra, India.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 500672 and on the National Stock Exchange(NSE) under NOVARTIND.

The Corporate was formerly known as Ciba (India) Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 32.00 Cr and a paid-up capital of Rs 12.35 Cr.

The company has closed loans amounting to ₹257.48 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Novartis India Limited India are Shilpa Joshi as CFO and Chandni Maru as Company Secretary. Falin Majmudar, Sandra Martyres, Christopher Snook, and Three other members serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    L24200MH1947PLC006104

  • Company No.

    006104

  • Stock Symbol

    BSE : 500672 NSE : NOVARTIND

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    13 Dec 1947

  • Date of AGM

    31 Jul 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Novartis India Limited offer?

Novartis India Limited offers a wide range of products and services, including Immunity Boosters, Antioxidant Supplements, Vitamins & Supplements, Vitamins A-Z, Mineral Supplements, Nutritional Drinks, For Adults, Health Conditions, Pain Relief, Bone, Joint & Muscle Care.

Company report

Novartis India Limited

Explore comprehensive data for Novartis India Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Novartis India?

Executive Team (2)

NameDesignationAppointment DateStatus
Shilpa Joshi Country flag representing In CFO22-Nov-2022Current
Chandni Maru Company Secretary20-May-2024Current

Board Members (6)

NameDesignationAppointment DateStatus
Sanker Parameswaran Country flag representing In Director 22-Jun-2020Current
Sandra Martyres Country flag representing In Director 19-Apr-2016Current
Gira Sardesai Country flag representing In Director 31-Mar-2024Current
Falin Majmudar Whole-Time Director 28-Jun-2024Current
Christopher Snook Country flag representing Gb Director 01-Aug-2008Current
Shilpa Joshi Country flag representing In Whole-Time Director and Cfo 22-Nov-2022Current

Financial Performance of Novartis India.

Novartis India Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.88% increase. The company also saw a substantial improvement in profitability, with a 2878.49% increase in profit. The company's net worth Soared by an impressive increase of 12.14%.

Novartis India revenue growth over time
Novartis India profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
0.88%
Revenue from Operations
-5.28%
Total Assets
2.65%
Profit or Loss
2878.49%
Net Worth
12.14%
EBITDA
140.06%

What is the Ownership and Shareholding Structure of Novartis India?

In 2023, Novartis India had a promoter holding of 70.68% and a public holding of 29.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹257.48 Cr

Charges Breakdown by Lending Institutions

  • Grindlays Bank : 111.60 Cr
  • Allahabad Bank : 45.00 Cr
  • Bnp Paribas : 33.00 Cr
  • Nationale De Paris French Bank Building : 32.50 Cr
  • The Industrial Credit And Investment Corpn. Of India Ltd. : 20.00 Cr
  • Others : 15.38 Cr

Latest Charge Details

DateLenderAmountStatus
12 Apr 1999Bnp Paribas₹33.00 CrSatisfied
02 May 1998The Hongkong And Shanghai Banking Corporation Ltd.₹5.00 CrSatisfied
21 Jul 1993Grindlays Bank₹45.00 CrSatisfied
21 Jul 1993Allahabad Bank₹45.00 CrSatisfied
28 May 1992Grindlays Bank₹38.00 CrSatisfied

How Many Employees Work at Novartis India?

Novartis India has a workforce of 59 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Novartis India Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Novartis India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novartis India's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Novartis India

Recent activity within the organization

  • Charges

    A charge registered on 06 Aug 1940 via Charge ID 90230132 with The National Bank Of India Ltd. was fully satisfied on 20 Aug 2024.

  • Annual General Meeting

    Novartis India Limited last Annual general meeting of members was held on 31 Jul 2024 as per latest MCA records.

  • Charges

    A charge registered on 21 Jul 1993 via Charge ID 90228667 with Grindlays Bank was fully satisfied on 01 Jul 2024.

  • Charges

    A charge registered on 17 Aug 1982 via Charge ID 90227632 with Grindlays Bank was fully satisfied on 01 Jul 2024.

  • Director Appointment

    Falin Ishwarlal Majmudar was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 28 Jun 2024 & has been associated with this company since 10 months 7 days .

  • Director Appointment

    Chandni Bhupendra Maru was appointed as a Company Secretary was appointed as a Company Secretary on 20 May 2024 & has been associated with this company since 11 months 16 days .

Recent News, Updates & Announcement

Frequently asked questions

  • What is the Incorporation or founding date of Novartis India Limited?

    Novartis India Limited was incorporated on 13 Dec 1947.

  • What is authorized share capital and paid-up capital of Novartis India Limited?

    The authorized share capital of Novartis India Limited is ₹ 32.00 Cr and paid-up capital is ₹ 12.35 Cr.

  • Who are the current board members & directors of Novartis India Limited?

    Currently 8 directors are associated with Novartis India Limited.

    • Falin Ishwarlal Majmudar
    • Sandra Martyres
    • Christopher David Snook
    • Sanker Parameswaran
    • Gira Jagdeesh Sardesai
    • Shilpa Shashank Joshi
    • Shilpa Shashank Joshi
    • Chandni Bhupendra Maru

  • What is the registered address of Novartis India Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Novartis India Limited is Inspire Bkc 7Th Floor Kurla Complex East India, Bandra, Maharashtra, 400051.

  • What is the corporate identification number (CIN) and company number of Novartis India Limited?

    The corporate identification number (CIN) of Novartis India Limited is L24200MH1947PLC006104 and the company number is 006104 as per Ministry of Corporate Affairs (MCA).

  • Is Novartis India Limited registered with any stock exchange in India?

    Yes, Novartis India Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): NOVARTIND.

  • What is the official website of Novartis India Limited?

    The Official website of Novartis India Limited is https://www.novartis.in

  • What has been the recent revenue trend for Novartis India Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Novartis India Limited has risen by 0.88%.

  • How many employees does Novartis India Limited currently have?

    As Per 2023 financial reports, 59 employees are currently employed by Novartis India Limited.

  • What change has been observed in the net worth of Novartis India Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Novartis India Limited has experienced an upsurge of 12.14%.

  • When was the last Balance Sheet of Novartis India Limited filed with the ROC?

    The most recent Balance Sheet for Novartis India Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development